Abstract
Background/Purpose: Polymyalgia rheumatica (PMR) is a common inflammatory disorder in the elderly. Geriatric syndromes as losses in activities of daily living, fraility, nutritional deficits and sarcopenia were conditions that become increasingly prevalent with age. Whilist PMR is a disease mostly affects geriatric population, there is a scarce data about PMR and possible accompanying geriatric syndromes. We examined prevalence of the accompanying geriatric syndromes in PMR patients and compare with age (±<5years) and sex matched controls.
Methods: Ten patients (8 female/2 male) diagnosed with PMR according to ACR/EULAR 2012 provisional PMR criteria and ten healthy controls were included to present study. Losses in activities of daily living was evaluated with Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) Nutritional status were assessed with Mini-Nutritional Assessment Short Form. Muscle strength evaluated with hand grip test. Patients with lowered muscle strength were labeled as probable sarcopenia according to The European Working Group on Sarcopenia in Older People (EWGSOP2) 2018.
Results:
The mean age was 75±7,9 for patients and 75,7±7,9 6,6 for controls (p=0.9). Mean hand grip strength was significantly lower in PMR patients (p=0.04) and probable sarcopenia was strikingly more common in patient group (p=0.01). Difference between the groups in terms of activities of daily living, nutritional status was non-significant.
Conclusion:
Higher prevalence of sarcopenia was disclosed at immune mediated rheumatic disease patients in the previous studies. Current study indicates that PMR patients were significantly more prone to probable sarcopenia. Further efforts are needed to ameliorate the patients’ care, quality of life and well-being.
Keywords
References
- 1- Gazitt T, Zisman D, Gardner G. Polymyalgia Rheumatica: a Common Disease in Seniors. Curr Rheumatol Rep. 2020 Jun 19;22(8):40.
- 2- González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet. 2017 Oct 7;390(10103):1700-1712.
- 3- Nakajima S, Chiba A, Makiyama A et al. Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica. Rheumatology (Oxford). 2020 Oct 1;59(10):2939-2946
- 4- Alvarez-Rodríguez L, Lopez-Hoyos M, Mata C et al.. Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis. 2010 Jan;69(1):263-9
- 5- Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum. 1995 Mar;38(3):369-73.
- 6- Fulop T, Larbi A, Dupuis G et al. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front Immunol. 2018 Jan 10;8:1960.
- 7- Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013). Frailty in elderly people. The Lancet, 381(9868), 752-762.
- 8- Dasgupta B, Cimmino MA, Maradit-Kremers H et. Al.. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329. PMID: 22388996; PMCID: PMC3298664.
- 9- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
- 10- Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983;31:721–7.
- 11- Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86.
- 12- Rubenstein LZ, Harker JO, Salvà A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001 Jun;56(6):M366-72. doi: 10.1093/gerona/56.6.m366. PMID: 11382797.
- 13- Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.
- 14- Sattui SE, Jannat-Khah D et. Al. Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia. Rheumatology (Oxford). 2022 Nov 2;61(11):4455-4464.
- 15- Ji Y, Li M, Chang M, Liu R, Qiu J, Wang K, Deng C, Shen Y, Zhu J, Wang W, Xu L, Sun H. Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants (Basel). 2022 Aug 29;11(9):1686.
- 16- Wendling D, Al Tabaa O, Chevet B et.al. Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica. Joint Bone Spine. 2024 Jul;91(4):105730.
- 17- Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013 Oct;45(10):2163-72.
- 18- Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech. 2013 Jan;6(1):25-39
- 19- Mahmood SB, Nelson E, Padniewski J, Nasr R. Polymyalgia rheumatica: An updated review. Cleve Clin J Med. 2020 Aug 31;87(9):549-556.
- 20- Nishioka S. Current Understanding of Sarcopenia and Malnutrition in Geriatric Rehabilitation. Nutrients. 2023 Mar 16;15(6):1426.
Details
| Primary Language | English |
|---|---|
| Subjects | Geriatrics and Gerontology, Rheumatology and Arthritis |
| Journal Section | Research Articles |
| Authors | |
| Early Pub Date | June 18, 2025 |
| Publication Date | |
| Submission Date | December 14, 2024 |
| Acceptance Date | December 27, 2024 |
| Published in Issue | Year 2025Volume: 16 Issue: Erken Çevrimiçi Yayınlar |